Concepedia

Yongjie Xie

YX

14

Publications

375

Citations

12

H-Index

2021

Active since

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Tianjin Medical University

Penn State Milton S. Hershey Medical Center

Nankai University

National Clinical Research

Yongjie Xie is an author at Tianjin Medical University Cancer Institute and Hospital specializing in immunology, medicine, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2021–2025

14

Publications

14

Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Tianxing Zhou, Yongjie Xie, Xupeng Hou et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 73 citations · Full text

ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4

Tianxing Zhou, Jing Liu, Yongjie Xie et al. · Gut · 2021 · 48 citations · Full text

SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation

Jing Liu, Weiwei Bai, Tianxing Zhou et al. · Gut · 2023 · 39 citations

Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells

Kaiyuan Wang, Bo Ni, Yongjie Xie et al. · Cell Research · 2025 · 37 citations · Full text

, , +12

Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy

Yongjie Xie, Tianxing Zhou, Xueyang Li et al. · Gastroenterology · 2024 · 29 citations

, , +7

Rows per page

1–5 of 14